SUSAN H. TANNENBAUM, MD

Plain English
This study looked at how the makeup of training teams impacts learning for healthcare professionals and students during teamwork training sessions. Out of over 14,000 studies reviewed, 11 were included, showing that the type of teams—whether made up of only one profession or a mix of different ones—can influence how well team members perform. Although findings indicated that mixed teams might slightly benefit from training, the evidence was very uncertain and highlights the need for more research to find the best team arrangements for effective training. Who this helps: This helps healthcare professionals and education programs aiming to improve teamwork skills.

Plain English
This study looked at how different racial groups fare after receiving chemotherapy for breast cancer. Researchers found that Black women were less likely to achieve a complete response to the treatment compared to White women, with only 85 out of 100 Black women reaching this goal compared to their White counterparts. For those who did not achieve this complete response, Black women had worse survival rates than White women, indicating that race plays a significant role in treatment outcomes. Who this helps: This research helps patients and doctors understand the need for improved treatments for Black women with breast cancer.

Plain English
This study focused on creating and testing a new tool called the Team Resilience Scale (TRS) to measure how well Army teams can adapt and stay strong under pressure. The researchers found that the TRS is reliable and can assess three key areas—physical, emotional, and mental resilience—showing that teams with higher resilience perform better and handle stressors effectively. This matters because it helps the Army understand how to support team dynamics and improve overall performance. Who this helps: This benefits Army personnel, leaders, and mental health professionals working with military teams.

Plain English
This project aimed to create online training materials to help scientists understand how modeling can inform drug development. Researchers developed 13 hours of videos featuring case studies from major pharmaceutical companies, which demonstrate the real-life applications of these models in making regulatory decisions. This training is important because it helps bridge the knowledge gap between academic training and practical applications in the drug development process. Who this helps: This benefits scientists, regulatory officials, and ultimately, patients by improving the drug approval process.

Plain English
This study looked at certain biological markers, called biomarkers, in patients receiving doxorubicin chemotherapy to see if they could indicate heart damage caused by the treatment. Researchers found that levels of specific cardiac biomarkers, like troponin T and GDF-15, increased after chemotherapy, while two non-cardiac biomarkers decreased. This finding is important because it could help identify patients at risk for heart problems before they show symptoms. Who this helps: This research benefits doctors and patients undergoing anthracycline chemotherapy by providing potential early warning signs of heart issues.

Plain English
This study looked at how handoffs—the process of transferring care from one healthcare provider to another—affect patient safety and continuity of care. It found that poor handoffs are responsible for 80% of serious medical mistakes and contribute to one in three malpractice lawsuits, leading to problems like loss of information and increased patient deaths. Improving handoffs is crucial because it directly impacts patient safety and healthcare quality. Who this helps: This helps patients and healthcare providers.

Plain English
This study focused on developing a framework called Team FIRST to identify the key teamwork skills necessary for healthcare providers. Researchers found that there are 10 essential competencies, such as effective communication and mutual trust, that improve how healthcare teams work together. These skills are crucial because better teamwork leads to improved patient care and healthcare outcomes. Who this helps: This benefits healthcare providers and ultimately improves care for patients.

Plain English
This study looked at how physical activity affects the quality of life for postmenopausal women with breast cancer who are taking aromatase inhibitors, a common treatment. Out of 170 women surveyed, about 50% met the recommended activity levels for leisure time, 65% walked regularly, and only 36.5% participated in strength training. While many women were active, the study found no clear link between meeting physical activity guidelines and improvements in their quality of life related to the treatment. Who this helps: This information helps doctors and healthcare providers better support postmenopausal breast cancer patients.

Plain English
This study looked at how the type of surgery (open or minimally invasive) affects the likelihood of cancer returning in women with early-stage high-intermediate risk endometrial cancer who received vaginal brachytherapy treatment. Among 494 patients, 65 (13.2%) had a recurrence, with those who had minimally invasive surgery experiencing a shorter time to recurrence and a higher risk overall (more than double, HR 2.29). These findings highlight that while minimally invasive surgery is popular, it may not be as safe as previously thought for this patient group. Who this helps: This helps patients diagnosed with early-stage high-intermediate risk endometrial cancer and their doctors in making informed treatment decisions.

Plain English
This study examined how the drug roxadustat behaves in the body of 2,855 patients with chronic kidney disease, both those on dialysis and those not. Researchers found that factors like body weight, race, and dosage affected how the drug was cleared from the body, but these factors did not significantly change its overall exposure levels. This is important because it shows that roxadustat's effectiveness and safety remain consistent across different patient groups. Who this helps: Patients with chronic kidney disease, especially those dealing with anemia.

Plain English
This study looked at how the drug mirabegron works in children and teenagers with bladder problems, such as neurogenic detrusor overactivity or idiopathic overactive bladder. Researchers found that the doses estimated based on a model using adult data provided levels of the drug in kids that were similar to what adults receive, and the treatment was generally safe and well-received, with no significant issues reported for the tablets and only mild complaints about the oral suspension. This information is important because it helps doctors determine the right doses of mirabegron for younger patients, ensuring they get effective treatment without unnecessary side effects. Who this helps: This research primarily benefits children and teenagers suffering from bladder issues.

Plain English
This study looked at how income affects the likelihood of breast cancer patients receiving a needle biopsy before surgery. Among nearly 10,000 Medicare patients studied, only 58.5% of those with low income received the biopsy, compared to 68.6% of higher-income patients. The differences in biopsy rates varied widely among different groups of doctors, which means that income disparities exist and could lead to unequal treatment for patients. Who this helps: This helps patients with breast cancer, particularly those from low-income backgrounds, by highlighting the need for more equitable healthcare practices.

Plain English
This study looked at how the drug solifenacin works in children and teenagers with overactive bladder or neurogenic detrusor overactivity. Researchers tested 194 patients and found that most (72.6%) were taking a higher dose of 10 mg daily, with drug absorption and clearance being similar across different age groups. This research is important because it helps doctors understand how to use solifenacin safely and effectively for young patients with these bladder issues. Who this helps: Patients with overactive bladder or neurogenic detrusor overactivity.

Plain English
This study looked at how early changes in hemoglobin levels and tumor type can predict how well breast cancer patients respond to chemotherapy before surgery. Researchers found that certain groups of patients, especially those with HER2-positive tumors, had a strong correlation between their hemoglobin levels before treatment and after the first cycle of chemotherapy, with an accuracy rate of 96% for predicting response. This is important because it could help doctors tailor treatments earlier, increasing the likelihood of a positive response and improving patient outcomes. Who this helps: This research benefits breast cancer patients by providing doctors with better tools to predict treatment success.

Plain English
This study looked at how potassium levels affect heart rhythms and the risk of death in patients experiencing certain heart conditions (non-ST-elevation myocardial infarction or unstable angina). Researchers found that patients with low potassium levels (below 3.5 mEq/L) had a significantly higher risk of heart problems and death. For example, the death rate at 14 days for these patients was 2.4%, compared to 0.8% for those with levels between 3.5 and 4 mEq/L, and this trend continued at one year, with 6.4% versus 3.0% respectively. Who this helps: This information is valuable for doctors caring for heart patients, allowing them to better manage potassium levels to reduce risks.

Plain English
This study looked at how chemotherapy affects the heart in women with early-stage breast cancer who are not at high risk for heart problems. The researchers found that over six months, the heart's pumping ability decreased slightly from 64% to 60%, while the size of the left ventricle increased, indicating changes in heart function. These findings are important because they show that while chemotherapy can alter heart structure and function, it does not seem to increase the risk of heart failure in these patients. Who this helps: This helps women undergoing breast cancer treatment and their doctors.

Plain English
This study looked at a 64-year-old man with aggressive male breast cancer and tested a new treatment method that combines two drugs targeting the HER2 protein, along with chemotherapy. The approach showed promising results, using a new imaging technique called ultrasound-localized diffuse optical tomography to track his response to treatment. This is important because it opens up new ways to treat male breast cancer, which is becoming more common and currently has limited treatment options. Who this helps: This helps patients with male breast cancer.

Plain English
This study looked at whether older women with localized breast cancer who lived in areas where more money is spent on cancer treatment had better chances of surviving the disease. The research included over 12,600 women and found that while the costs of care ranged widely—from about $13,338 to $26,831—there was no clear link between higher spending and improved survival rates; for example, the survival rates at three years varied from 66.7% to 92.2% based on location, but spending did not make a difference in outcomes. This matters because it suggests that simply spending more on cancer care doesn’t necessarily lead to better results for patients, highlighting the need to focus on getting better value from treatment. Who this helps: This helps doctors and healthcare providers understand that increased spending does not guarantee better care for breast cancer patients.

Plain English
This research paper looks at how a new imaging technique called ultrasound-guided diffuse optical tomography (US-guided DOT) can help predict and track how well breast cancer patients respond to chemotherapy before surgery. The study highlights the progress in making this imaging technology more portable and practical for use in different healthcare settings. One example shared in the paper is of a patient who was monitored at several stages during her chemotherapy, showing promising results in tracking treatment effects. Who this helps: This benefits patients undergoing breast cancer treatment and their doctors by providing better monitoring tools.

Plain English
This study looked at how a special program to teach parents improved the way they communicate with their deaf or hard-of-hearing children from low-income backgrounds. They found that after the program, parents showed better knowledge about language development and increased the number of words and sentences they used when speaking to their children. These changes are important because they can help create a richer language environment for kids, which is crucial for their communication skills. Who this helps: Parents and their deaf or hard-of-hearing children from low-income families.

Plain English
This study examined how a new imaging technique called ultrasound-guided diffuse optical tomography can help differentiate between malignant (cancerous) and benign (non-cancerous) breast lesions by measuring levels of hemoglobin in the tissue. The researchers found that malignant lesions had significantly higher average levels of total hemoglobin (89.3 µmol/L) compared to benign ones (54.1 µmol/L), which helps improve the accuracy of breast cancer diagnoses. This method, when combined with standard ultrasound, resulted in a very high sensitivity (96.6%-100%) for detecting malignant lesions, making it a valuable tool for better diagnosis. Who this helps: This research benefits patients undergoing breast cancer evaluation and doctors in the diagnosis process.

Plain English
This study looked at whether adding a drug called bortezomib would make another drug, fulvestrant, more effective for postmenopausal women with hormone receptor-positive metastatic breast cancer that had stopped responding to standard treatments. While the study did not find a significant improvement in the overall time patients lived without the disease worsening (2.7 months for both groups), those taking the combination therapy had a higher chance of still being progression-free at 12 months: 28.1% compared to 13.6% for those on fulvestrant alone. This matters because it suggests that bortezomib might help some patients overcome resistance to treatments they’ve already tried. Who this helps: This helps women with advanced breast cancer that is resistant to other hormone treatments.

Plain English
This study looked at a patient with early breast cancer who developed a rash more than a week after receiving the drug pegfilgrastim, which is used to boost white blood cell counts in cancer patients. The authors highlighted the importance of recognizing that some patients may experience delayed allergic reactions to pegfilgrastim, which could potentially postpone their chemotherapy treatment. This matters because timely cancer treatment is crucial for improving outcomes. Who this helps: Patients undergoing chemotherapy.

Plain English
This research paper looks at heart failure with preserved ejection fraction (HFpEF), a complex condition affecting many patients. It found that current treatments are not effective because HFpEF varies widely among patients, and there’s a need for more tailored therapies based on different patient groups. About half of all chronic heart failure patients have HFpEF, which can lead to serious health problems and risks of death, making it crucial to find better treatments. Who this helps: This helps patients with heart failure, especially those with HFpEF, by paving the way for more effective, personalized treatments.

Plain English
Researchers studied the best dosing of daptomycin, an antibiotic, for treating patients with Staphylococcus aureus bacteraemia (SAB) who also have severe kidney issues. They found that using a dose of 6 mg/kg every 48 hours is more effective and safe compared to 4 mg/kg every 48 hours, especially since many patients were underexposed to the drug at the lower dose. This information is important because it helps ensure that patients receive the right amount of medication to effectively treat their infection without exceeding safety limits. Who this helps: This helps patients with Staphylococcus aureus bacteraemia and severe kidney impairment.

Plain English
The research focused on the work of a committee dedicated to improving how drug effects are analyzed in populations. They aim to create consistent and high-quality methods for studying how drugs act in the body and how they can influence health outcomes. This is important because better analyses lead to more informed decisions about medications, ultimately improving patient care. Who this helps: This benefits patients and healthcare providers by ensuring that drug treatments are based on reliable information.

Plain English
This study looked at how specific measurements of hemoglobin in tumors could help predict how well patients would respond to chemotherapy before they actually start treatment. Researchers analyzed data from 34 patients and found that using measurements of total hemoglobin (tHb) along with traditional tumor characteristics improved prediction accuracy: sensitivity rose from about 57% to 79%, and specificity went up from 89% to 94%. This is important because better predictions can guide treatment decisions, helping doctors choose the best course of action for their patients. Who this helps: This helps patients by allowing for more personalized and effective treatment plans.

Plain English
This study looked at how taking high doses of fish oil, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), affects bone loss in postmenopausal women with breast cancer who are taking aromatase inhibitors, which can weaken bones. In a group of 38 women, those who took the fish oil showed decreased bone resorption compared to those who did not, indicating a potential benefit in preserving bone health. The results highlight that these fatty acids may help protect against bone loss in a population already at high risk for fractures. Who this helps: This helps postmenopausal breast cancer survivors at risk of bone loss.

Plain English
This study examined the drug canakinumab, which is designed to target a protein called IL-1β that causes inflammation in the body. Researchers found that in patients with a specific genetic condition, canakinumab had a slow clearance rate from the body, taking about 26 days for half of it to disappear, and it effectively binds to IL-1β. These findings are important because they help establish how canakinumab works in treating various inflammatory diseases, such as rheumatoid arthritis and asthma, which can lead to better treatment outcomes. Who this helps: This helps patients with inflammatory diseases and their doctors in managing treatment options.

Plain English
This study examined a 57-year-old woman who developed serious heart problems 17 years after receiving chemotherapy with doxorubicin for breast cancer. Despite her long time without heart issues, she experienced heart failure, but after receiving targeted treatment, her heart function improved significantly, going from a very low ejection fraction of 20% to 55% in just 8 months. This finding highlights that even years after treatment, doxorubicin can harm the heart, and it’s important for healthcare providers to monitor survivors for potential heart problems long after their cancer treatment ends. Who this helps: This helps breast cancer survivors and their doctors.

Plain English
This study focused on creating guidelines to improve the quality of population modeling and analysis in medical research, particularly using a software called NONMEM. The authors identified specific areas that need attention, such as the installation of the software and how data is processed and reported, to ensure accurate and reliable results. These guidelines are important because they help ensure that research findings truly represent the data collected, leading to better understanding and treatment options in healthcare. Who this helps: Patients and healthcare providers who rely on accurate research for effective treatments.

Plain English
This study looked at how women felt emotionally and physically before and after having a breast biopsy, focusing on issues like anxiety, depression, fatigue, and sleep problems. Out of 47 women, 15 were diagnosed with breast cancer while 32 were not, and many women reported significant anxiety and sleep issues before and after the procedure. This is important because it reveals that many women face ongoing distress related to their health situation, regardless of biopsy results. Who this helps: This helps women undergoing breast biopsies and their healthcare providers.

Plain English
This study looked at how well a medication called canakinumab works for children with a rare disease called cryopyrin-associated periodic syndrome (CAPS), which causes painful and severe inflammation. All seven pediatric patients in the study responded completely to the treatment within a week, and on average, they remained symptom-free for about 49 days before experiencing another flare-up. This is important because it shows canakinumab can effectively manage symptoms in these patients, improving their quality of life. Who this helps: This benefits children with CAPS and their families by providing a treatment that can control their symptoms effectively.

Plain English
This study examined genetic differences between two types of breast cancer: estrogen receptor (ER)-positive and ER-negative. The researchers found that ER-negative cancers had more genetic changes and imbalances compared to ER-positive tumors, particularly in the form of copy number aberrations (CNAs) and loss of heterozygosity (LOH). Specifically, they noted significant deletions on chromosome 5 (5q) and increased DNA in certain areas (2p and 21q) in ER-negative samples, as well as a notable connection to BRCA1 gene mutations. Who this helps: This research benefits doctors and scientists working to improve breast cancer diagnosis and treatment strategies.

Plain English
This study looks at how to determine safe starting doses for new biotherapeutic drugs in human trials by analyzing how these drugs bind to their targets in the body. Researchers found that using models to predict drug interactions and effects can help identify appropriate doses, as seen in their work with the drug omalizumab, which safely suppressed free IgE levels. This approach is important because it can prevent harm during early clinical trials and improve drug development by ensuring that initial doses are both safe and effective. Who this helps: This benefits patients participating in clinical trials and the doctors overseeing their treatment.

Plain English
This study looked at how using detailed mathematical models, known as pharmacometrics, is changing the way drugs are developed in the pharmaceutical industry. Researchers surveyed ten pharmaceutical companies and found that these models are increasingly being used in the early and later stages of drug development, positively influencing decisions about dosages and study designs. However, the use of such models is still limited in the early stages of drug discovery and commercial decisions. This is important because improving decision-making processes can lead to more effective drugs getting to patients faster. Who this helps: This helps patients and pharmaceutical companies by improving drug development processes.

Plain English
This study looked at how the medication omalizumab, used for severe allergic asthma, interacts with a molecule called IgE and how that affects patients' symptoms. Researchers analyzed data from 1,781 patients and found that keeping the level of free IgE at 14 ng/ml significantly improved asthma symptoms over four weeks. This is important because it suggests that current dosing could be adjusted for patients with higher IgE levels to enhance treatment effectiveness. Who this helps: This helps patients with severe allergic asthma and their doctors by providing better dosing options.

Plain English
This study explored a new method for tracking breast cancer during chemotherapy using a tool that combines light imaging and ultrasound. The researchers found that different groups of patients responded to treatment in varying degrees, with complete responders showing a blood volume index (a measure of tumor blood flow) of 29.1%, while nonresponders had levels around 86.8%. This technology is important because it could help doctors monitor how well the chemotherapy is working and adjust treatments accordingly. Who this helps: This helps patients undergoing breast cancer treatment and their doctors.

Plain English
This research developed a new system to closely observe how cancer cells spread to the liver, which is an important step in many cancers and usually leads to serious health problems. The scientists created a special 3D culture that mimics liver tissue, allowing them to see how prostate and breast cancer cells invaded the liver over 14 days. They found that cancer cells could form visible tumors without damaging the liver tissue, indicating that the liver offers crucial support for tumor growth. Who this helps: This benefits patients with metastatic cancers, doctors, and researchers focused on cancer treatment.

Plain English
This study examined a new method called optical tomography with ultrasound to improve breast cancer diagnosis and treatment monitoring. Researchers used a handheld device that combines ultrasound and near-infrared optical imaging to create clearer images of tumors, successfully measuring important factors like hemoglobin concentration and blood oxygen levels in patients. This new approach allows doctors to better diagnose breast cancer and assess how well chemotherapy is working. Who this helps: Patients undergoing treatment for breast cancer.

Plain English
This study focused on how to prevent blood clots in patients undergoing rehabilitation after surgery or serious medical illnesses. Experts from rehabilitation centers in South Florida came together to review existing studies and share best practices, leading to a set of recommendations that detail the most effective ways to reduce the risk of blood clots, including medications and physical aids. This matters because blood clots can lead to serious complications, and by improving prevention strategies, patients can recover more safely and effectively. Who this helps: This helps patients undergoing rehabilitation therapy.

Plain English
This study looked at a new way to use light and sound to better detect breast tumors based on their size and depth in the body. Researchers found that using a high frequency of 350 MHz is best for small, shallow lesions, while a lower frequency of 50 MHz works better for larger, deeper tumors. This is important because it helps doctors get more accurate information about tumors, which can improve treatment planning. Who this helps: This helps doctors and breast cancer patients by providing better imaging techniques for accurate diagnosis.